A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Hypochondroplasia

In brief

The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52-week period.

Key facts

Study ID
NCT07126262
Run by
BioMarin Pharmaceutical
People needed
60
Starts
2025-07-30
Expected to finish
2028-06-30
Last updated by the study team
2026-03-31

Who can join

Age: any, up to 3. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.